Most surgical robots are judged by what they can do on the day they ship. The da Vinci 5, Intuitive’s fifth generation multiport system, was built to be judged differently: by how much it can learn to do afterward. Two and a half years after its U.S. clearance, the platform has picked up the sense of touch in Europe, cardiac indications across three continents, more than 100 software updates and a stated path toward remote surgery. It is quickly becoming the clearest example of a surgical robot that behaves more like a software platform than a fixed piece of capital equipment.
From the first da Vinci to a fifth generation
Intuitive’s da Vinci family has evolved from early multiport systems through the da Vinci X and Xi, plus the single port da Vinci SP for narrow access procedures. When the U.S. Food and Drug Administration granted 510(k) clearance for da Vinci 5 in March 2024, then CEO Gary Guthart described it as the product of more than a decade of research, design, development and testing, according to Intuitive’s clearance announcement. The company said the system builds on the Xi design, which had been used in more than 7 million procedures at the time, and adds more than 150 enhancements.
The headline numbers at launch were about raw capability. Intuitive reported more than 10,000 times the computing power of the Xi, a next generation 3D display and image processing, refined tremor and vibration control, and integrated operating room equipment such as insufflation and an electrosurgical unit. The rollout was deliberately cautious: the company said da Vinci 5 would first go to a small number of U.S. customers with mature robotic programs so it could gather data before a wider launch.
Giving the robot a sense of touch
The most distinctive feature is Force Feedback. Earlier da Vinci systems relied almost entirely on vision, so surgeons had to infer how hard they were pulling on tissue from what they saw on screen. On da Vinci 5, optional instruments measure push, pull and directional forces and let the surgeon feel them through the hand controls. Intuitive’s da Vinci 5 product page says the sensors check their accuracy roughly 1,000 times per second, are optimized for a sensing range of 0 to 6.5 newtons, and that surgeons applied up to 43% less force on tissue in preclinical testing comparing high feedback settings to feedback switched off. There are six Force Feedback instruments covering dissection, retraction and suturing, and Intuitive notes a contraindication for the Force Feedback needle driver in hysterectomy and myomectomy.
The feature reached Europe in September 2026, when Intuitive announced CE mark approval for Force Feedback instruments, according to its European newsroom release. The release also introduced Force Gauge, a speedometer style on screen indicator of relative force, and post operative force metrics surgeons can review in Case Insights. Adoption is still early. On the third quarter 2026 earnings call, CFO Jamie Samath said about 8% of da Vinci 5 cases used Force Feedback instruments, a figure he linked partly to supply that only reached full availability late in the quarter.
A robot that keeps getting software updates
Intuitive has leaned hard into the idea of a future ready platform. In May 2026 the company announced more than 100 updates and user experience improvements for da Vinci 5 users, according to its May 2026 announcement. They include a Telepresence camera that shows remote mentors the full operating room, a live cursor and better audio for remote guidance, phone tap login to the surgeon console with multifactor authentication, and six new SimNow 2 simulation exercises. The same release said five of the six Force Feedback instruments had their permitted uses raised from six to 15, a change aimed at cost per case.
Further features followed through regulatory review. On the October 2026 earnings call, CEO Dave Rosa said da Vinci 5 received FDA 510(k) clearance for surgeon initiated tool eject and multi arm targeting during the third quarter, and that the system is now cleared for cardiac procedures in the U.S., Europe, India, Japan and Korea. He also described work on a voice activated interface and automated control of the fourth arm, while cautioning that AI controlled motion must earn the confidence of regulators, surgeons and patients before it is deployed at scale.
Adoption is accelerating
The business numbers show customers moving to the new platform. Intuitive’s third quarter 2026 results report 546 da Vinci systems placed in the quarter, of which 315 were da Vinci 5, up from 240 a year earlier, and a total da Vinci installed base of 12,094 systems. On the call, Rosa said more than 2,000 da Vinci 5 systems were installed worldwide, used by more than 18,000 surgeons since launch, and Samath said da Vinci 5 accounted for more than a quarter of U.S. da Vinci procedures, up from 13% a year earlier. International placements are rising too: 41 of the quarter’s da Vinci 5 placements were outside the U.S., compared with 12 a year before.
The next frontier: surgery at a distance
Telepresence on da Vinci 5 already lets an expert observe and guide a case remotely. Intuitive sees it as the first step toward telesurgery, in which the surgeon operates the robot from another location. Rosa said on the earnings call that the company expects several telesurgery regulatory clearances in the first half of 2028. Context matters here: MedTech Dive reports that no surgical robot is currently authorized in the U.S. for remote procedures, that Intuitive is developing telesurgery technology for da Vinci 5, and that the company says success will depend on networks, regulation, reimbursement, licensing and trust as much as on the robot itself.
What it means
For hospital leaders, da Vinci 5 changes the purchasing question. Because capability arrives through software and new instruments, a system bought today should do more in three years than it does now, which strengthens the case for treating it as a long lived platform rather than a fixed asset. For clinical teams, force sensing adds a measurable data stream about how gently tissue is handled, opening the door to objective feedback in training and, potentially, outcome research. For IT and operations teams, the platform brings familiar enterprise concerns into the operating room: connected consoles, multifactor login, remote collaboration and analytics pipelines that need reliable networks and governance.
The caveats deserve equal weight. Many of the performance claims come from Intuitive’s own preclinical studies or early experience, and Force Feedback use is still a small share of cases. Telesurgery remains investigational, and the company itself frames AI driven motion as a long term ambition rather than a near term product.
Conclusion
The da Vinci 5 story is less about a single new robot than about a new model for surgical technology: launch a powerful base platform, then keep adding senses, software and connectivity. If the evidence for Force Feedback grows and remote surgery clears its regulatory hurdles, the fifth generation da Vinci may be remembered as the point where surgical robots became continuously upgradable systems.
Sources
- Meet the da Vinci 5 robotic surgical system, Intuitive
- Intuitive Announces FDA Clearance of Fifth-Generation Robotic System, da Vinci 5, Intuitive (March 2024)
- Intuitive Announces Innovations to Advance Quintuple Aim, Intuitive (May 2026)
- Intuitive advances da Vinci 5 innovations in Europe, Intuitive (September 2026)
- Intuitive Announces Third Quarter Earnings, Intuitive (October 2026)
- Intuitive Surgical (ISRG) Q3 2026 Earnings Call Transcript, The Motley Fool
- Telerobotic surgery is advancing around the world. Will the US embrace it?, MedTech Dive